Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 07. November 2025
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2124  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 42480  
   
Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis.
Neurologia (Engl Ed)
Rivero-de-Aguilar A, Mascareñas-García M, Pérez-Ríos M, Llaneza-Gonzalez MA, Mulero P, Mendibe M, Rovira À, Meca-Lallana V, García-Ruiz AJ, Landete L, Vizoso Hermida JR, Carrascal Rueda P, Ruano-Raviña A, Puente-Hernandez M, Varela-Lema L.
PMID: 41198383 [PubMed - indexed for MEDLINE]


Management of neuropathic pain and paresthesia in patients with multiple sclerosis: A systematic review and network meta-analysis.
Mult Scler Relat Disord
Mohamadi M, Molla A, Sadeghi E, Orakifar N, Bahari M, Yekta ZM, Bervis S, Hesampour K, Shokri E.
PMID: 41197398 [PubMed - as supplied by publisher]


Falls Prevalence and Fear of falling in Multiple Sclerosis: A Systematic-Review and Meta-Analysis.
Eur Neurol
Giannopapas V, Smyrni V, Kitsos DK, Stasi S, Chasiotis AK, Stavrogianni K, Akrivaki A, Dimitriadou EM, Tzanetakos D, Bakalidou D, Tzartos JS, Tsivgoulis G, Giannopoulos S.
PMID: 41196814 [PubMed - as supplied by publisher]


Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study.
J Neurol
Hua LH, Brown B, Camacho E, Chinea AR, Greenberg BM, Henry RG, Houtsma E, Moreo N, Alvarez E.
PMID: 41196386 [PubMed - indexed for MEDLINE]


Glucagon‑Like Peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions.
Expert Opin Investig Drugs
Shirani A, Stuve O.
PMID: 41196232 [PubMed - as supplied by publisher]


Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
Mult Scler
Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves JS.
PMID: 41195728 [PubMed - as supplied by publisher]


The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case-Control Study.
Pharmacoepidemiol Drug Saf
Leung MWY, van de Garde EMW, Uitdehaag BMJ, Souverein PC, Klungel OH, Bazelier MT.
PMID: 41195597 [PubMed - indexed for MEDLINE]


Classification of patients with early-stage multiple sclerosis and healthy controls using kinematic analysis during a dual-task.
Front Artif Intell
Garotti JER, Speciali DS, de Azevedo Neto RM, Aguiar PMC, Thomaz RB, Sowmy TAS, Brech GC, Bazán PR, Kozasa EH.
PMID: 41195195 [PubMed]


The Serum Lipid Profile of Relapsing Multiple Sclerosis Differs Reproducibly From Healthy Controls.
J Neurochem
Shi L, Ghezzi L, Watt G, Mainali D, Perantie D, Fenoglio C, Tran C, Dupuy A, Passam F, Sen MK, Chan H, Kwok S, Wang C, Barnett M, Hardy T, Piccio L, Don AS.
PMID: 41194399 [PubMed - indexed for MEDLINE]


Development and psychometric properties of the caregiver sense of competence questionnaire for caregivers of people with multiple sclerosis (CareSoC-MS): a cross-sectional study.
BMJ Open
Tacchino A, Podda J, Verri A, Battaglia MA, Brichetto G, Ponzio M.
PMID: 41193215 [PubMed - indexed for MEDLINE]


Therapeutic exercise in multiple sclerosis: Mechanisms of neuroprotection, modality-specific benefits, and technology-enhanced delivery frameworks.
Mult Scler Relat Disord
Shirvani H, Arabzadeh E.
PMID: 41192213 [PubMed - as supplied by publisher]


A survey of diagnostic and treatment practices for multiple sclerosis in Turkey.
Mult Scler Relat Disord
, Sefero, Ayd, Karabudak R.
PMID: 41192212 [PubMed - as supplied by publisher]


Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group.
Neurol Ther
Alroughani R, Celius EG, Gray H, Kasilingam E, Kruger P, Montague A, Oreja-Guevara C, Plant A, Pontaga M, Rieckmann P, Ritter L, Sumelahti ML.
PMID: 41191274 [PubMed - as supplied by publisher]


Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment.
J Neurol
Waskowiak PT, de Jong BA, Uitdehaag BMJ, Myronenko A, Hulst HE, Klein M, Don´t be late! consortium.
PMID: 41191127 [PubMed - indexed for MEDLINE]


Benign multiple sclerosis and long-term outcomes after 30 years.
J Neurol
Matas E, Bau L, Romero-Pinel L, León I, Arroyo-Pereiro P, Muñoz-Vendrell A, Martínez-Yélamos A, Martínez-Yélamos S.
PMID: 41191123 [PubMed - indexed for MEDLINE]


Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
Mult Scler
Selmaj KW, Steinman L, Comi G, Bar-Or A, Arnold DL, Hartung HP, Montalbán X, Havrdová EK, Sheffield JK, Krakovich A, Cheng CY, Riolo JV, Pachai C, Thorpe A, DeBoer E, Kappos L, Cohen JA, Cree BA.
PMID: 41190505 [PubMed - indexed for MEDLINE]


Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
Mult Scler
Sandgren S, Maceski AM, Benkert P, Einsiedler M, Schaedelin S, Oechtering J, Achtnichts L, Lalive PH, Müller S, Pot C, Heslegrave A, Hunt D, Lycke J, Hoepner R, Roth P, Gobbi C, Comabella M, Derfuss T, Kappos L, Granziera C, Abdelhak A, Leppert D, Willemse EA, Zetterberg H, Kuhle J.
PMID: 41190504 [PubMed - indexed for MEDLINE]


Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis.
Front Immunol
López-Molina M, Torres Iglesias G, Sáenz de Santa María-Diez G, Valentín-Quiroga J, Laso-García F, Gallego R, Pozo-Novoa J, Chamorro B, López-Collazo E, Puertas I, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L.
PMID: 41190076 [PubMed - indexed for MEDLINE]


Entertainment activities and the risk of multiple sclerosis: A Mendelian randomization analysis.
Medicine (Baltimore)
Wang Z, Wu W.
PMID: 41189227 [PubMed - indexed for MEDLINE]


Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapies.
Medicine (Baltimore)
Berkovich R, Greene N, Reddy SR, Chang E, Tarbox MH, Fadaee S, Quach C, Pyatkevich Y.
PMID: 41189204 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 42480    Seite 1 von 2124  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1